drugset / Trial / NCT02353858

Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer

NCT02353858 ↗

Phase 2 Completed 78 enrolled University Hospital Tuebingen
NaSingle-groupOpen-labelTreatment

Summary

The current trial is evaluating the impact of deep regional hyperthermia on the pathological complete response rate in locally advanced rectal cancer in the context of preoperative 5FU based radiochemotherapy.

Timeline

Start
2012-08
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject fluorouracil Small molecule 1000 mg/m2 Intravenous

Indications